Strolll Limited

Strolll Limited develops Reality DTx®, a digital therapeutic software platform for augmented reality (AR) glasses designed for neurorehabilitation. The solution uses transparent, see-through AR lenses that blend digital content with physical space, enabling clinicians to deliver immersive therapy in real-world environments—clinic or home. The platform captures objective, clinically relevant data during both in-clinic and at-home rehabilitation sessions, supporting remote monitoring and automated clinical documentation. Strolll integrates into existing clinical workflows for synchronous or asynchronous therapy delivery, reducing administrative burden while enabling real-time patient oversight. The platform addresses gait training, mobility improvement, fall prevention, and functional recovery across neurological conditions including Parkinson's disease, stroke, and generalized balance disorders. Regulatory credentials include CE marking, UKCA certification, FDA clearance, NHS Data Security and Protection Toolkit (DTAC) compliance, and DCB0129 designation. The company collaborates with NHS facilities, private rehabilitation centers, physiotherapy practices, and academic institutions across the UK and US. Target users are physical therapists, occupational therapists, and rehabilitation specialists managing both outpatient and home-based programs.